Tetrabenazine

Tetrabenazine is a medication used to treat certain movement disorders. It works by affecting brain chemicals. It's important to take it exactly as prescribed by your doctor.

Brand names:Nitoman, Xenazine
Medication

What people taking Tetrabenazine report

Every report comes from a Lived member, sent anonymously.

Have you tried Tetrabenazine for Chorea?

NameHow it went

About Tetrabenazine

What It's For

Tetrabenazine, sold as Xenazine and as generic tablets, is a prescription medicine for chorea caused by Huntington's disease. Chorea is the involuntary, irregular, flowing movement that many people with Huntington's develop. It can make walking, eating, writing and other everyday tasks harder and can lead to falls and injuries. Tetrabenazine reduces these movements. It does not slow Huntington's disease, and it does not improve thinking, mood or the other changes the illness brings. Doctors sometimes prescribe it off-label (for a use the FDA has not approved) for other disorders of excess movement, including tardive dyskinesia (repetitive movements caused by long-term use of certain psychiatric medicines), tics in Tourette syndrome and some forms of dystonia. Evidence for these uses comes mostly from smaller, less rigorous studies. Two newer medicines in the same family, deutetrabenazine (Austedo) and valbenazine (Ingrezza), are approved for both Huntington's chorea and tardive dyskinesia, so they are often weighed as alternatives.

How It Works

Nerve cells store chemical messengers such as dopamine, serotonin and norepinephrine in tiny sacs before releasing them to signal other cells. Tetrabenazine blocks a transporter called VMAT2 (vesicular monoamine transporter 2) that loads these messengers into the sacs, so less of them is available to release. Reduced dopamine signaling in the brain's movement circuits is thought to be why chorea quiets down, although the exact mechanism is not fully understood. Because the drug lowers several messengers rather than dopamine alone, its effects reach beyond movement. This is consistent with its main unwanted effects: low mood, sleepiness, and slowness or stiffness similar to Parkinson's disease. The effect is reversible and wears off within about a day of the last dose.

Dosage & Administration

Tetrabenazine is a tablet taken by mouth, with or without food. Treatment starts at a low dose once a day, and the prescriber raises it in small steps about once a week until chorea improves or side effects get in the way. Finding the right dose usually takes several weeks. At moderate doses it is split into three doses a day. Before going above 50 mg a day, the label calls for a CYP2D6 genetic test. CYP2D6 is a liver enzyme that breaks down tetrabenazine, and some people inherit a slow version that leaves much higher drug levels in the blood, so their maximum dose is lower. The same limit applies to people taking medicines that block this enzyme, such as the antidepressants fluoxetine and paroxetine or the heart rhythm drug quinidine. If treatment is interrupted for more than five days, the dose is usually built up again from the start rather than resumed at the old level.

Side Effects

Sleepiness is the most common side effect and the one that most often limits the dose. In the main clinical trial it affected about a third of people, and lowering the dose usually helped. Fatigue, trouble sleeping, anxiety, nausea and balance problems are also common. Avoid driving or operating machinery until you are on a steady dose and know how the medicine affects you. Two movement-related effects are worth knowing by name. Akathisia is an inner restlessness and urge to keep moving. Parkinsonism means slowness, stiffness or a shuffling walk, and for some people it can be more disabling than the chorea it replaces. Because Huntington's disease can cause similar changes, a dose reduction is often how the care team tells the two apart. Report these, along with new difficulty swallowing or choking on food or drink, to the prescriber promptly; swallowing problems can lead to pneumonia. Some people also feel dizzy when standing up. Rarely, tetrabenazine causes neuroleptic malignant syndrome, a dangerous reaction to drugs that reduce dopamine. High fever with stiff muscles, confusion, heavy sweating or a fast or irregular heartbeat needs emergency medical care right away.

Interactions & Warnings

Tetrabenazine carries an FDA boxed warning: it can increase depression and suicidal thoughts and behavior in people with Huntington's disease, who already face a higher risk of both. In the main trial, about one in five people taking it developed new or worsening depression. It is not used in people who are actively suicidal or whose depression is untreated or not well controlled. People taking it, and their families, should contact the prescriber right away about new or worsening sadness, withdrawal, irritability, agitation or any thoughts of suicide or self-harm. It should not be taken by people with liver impairment, or together with MAOIs (an older class of antidepressants; at least 14 days must pass after stopping one), reserpine (an older blood pressure drug; at least 20 days), deutetrabenazine or valbenazine. Antipsychotic medicines can add to its risks of parkinsonism, akathisia and neuroleptic malignant syndrome. Tetrabenazine slightly lengthens the QT interval, a measure of the heart's electrical recovery between beats, so it is avoided in people with congenital long QT syndrome or a history of heart rhythm problems and is generally not combined with other drugs that lengthen QT. Alcohol and other sedating medicines make drowsiness worse. There is little human data on use in pregnancy, and animal studies showed harm to offspring, so anyone pregnant, planning pregnancy or breastfeeding should discuss it with the prescriber.

What to Expect

Chorea often begins to ease as the dose is raised, and the full effect becomes clear once a stable, tolerated dose is reached over several weeks. In the main 12-week trial, about half of people taking tetrabenazine had a substantial drop in chorea, compared with fewer than one in ten on placebo. Fewer involuntary movements did not translate into better day-to-day function or thinking, and the trial found slight worsening in mood, thinking, stiffness and daily function on the drug. Whether those changes persist over longer use is unknown. For that reason, treatment involves regular check-ins on mood, alertness, swallowing, stiffness and how much the movements actually interfere with life. Chorea can change as Huntington's progresses, and sometimes lessens, so the need for the medicine is reassessed over time. Tetrabenazine does not need to be tapered, but chorea typically returns within 12 to 18 hours of the last dose, so stopping or changing treatment is best planned with the prescriber.

Questions to Ask Your Doctor

  1. 1.How much is chorea affecting my daily life, and is it worth treating given the risk of depression and sleepiness?
  2. 2.Why tetrabenazine rather than deutetrabenazine or valbenazine for me?
  3. 3.How will we monitor my mood, and who should my family call if they notice changes?
  4. 4.Will I need a CYP2D6 genetic test, and do any of my current medicines limit my dose?
  5. 5.How will we tell whether stiffness, slowness or swallowing trouble is from the medicine or from Huntington's disease?

Last reviewed • Oct 2026

Educational content, not medical advice.